Back to top
more

Utz Brands (UTZ)

(Real Time Quote from BATS)

$12.98 USD

12.98
23,693

-0.24 (-1.82%)

Updated Aug 6, 2025 09:52 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 22% (191 out of 246)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

by Zacks Equity Research

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.

Zacks Equity Research

Nomad Foods (NOMD) Reaffirms Q3 & Full-Year 2023 Guidance

by Zacks Equity Research

Nomad Foods (NOMD) continues to expect revenues in the range of EUR750-EUR755 million for the third quarter of 2023.

Zacks Equity Research

B&G Foods (BGS) Gains on Pricing Actions & Prudent Buyouts

by Zacks Equity Research

B&G Foods' (BGS) pricing actions have been catching up with higher costs. The company has a successful track record of acquisition-led growth.

Zacks Equity Research

Can Strategic Growth Endeavors Aid Newell (NWL) Amid Inflation?

by Zacks Equity Research

Despite inflationary pressures, Newell (NWL) looks promising on the back of cost-cutting initiatives and a solid online show.

Zacks Equity Research

Factors That Make Helen of Troy (HELE) an Attractive Bet Now

by Zacks Equity Research

Helen of Troy (HELE) benefits from its focus on a solid Leadership Brand portfolio. The company's global restructuring plan, Project Pegasus, is worth mentioning.

Zacks Equity Research

Strategic Pricing Actions Aid Lamb Weston (LW), High Costs Ail

by Zacks Equity Research

Lamb Weston (LW) benefits from robust pricing actions to counter input and manufacturing cost inflation.

Zacks Equity Research

Hormel Foods (HRL) Stock Dips on Q3 Earnings & Sales Miss

by Zacks Equity Research

Hormel Foods' (HRL) third-quarter fiscal 2023 results reflect weakness in the Retail and International segments. Continued momentum in the Foodservice unit acts as an upside.

Zacks Equity Research

Church & Dwight (CHD) Up More Than 15% YTD: Will It Stay?

by Zacks Equity Research

Constant brand investments, product innovation, effective pricing actions and successful execution are contributing to Church & Dwight's (CHD) growth.

Zacks Equity Research

Strength in Brand Portfolio Aids Kellogg (K), Rising Costs Ail

by Zacks Equity Research

Kellogg (K) is focused on investing in brand-building efforts. However, adverse impacts of high input cost inflation and shortages are a concern.

Zacks Equity Research

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

by Zacks Equity Research

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.

Zacks Equity Research

Accelerate Strategy Aids General Mills (GIS), High Costs Hurt

by Zacks Equity Research

General Mills (GIS) is focused on its Accelerate strategy, which helps it make choices of how to win and where to play to boost profitability. However, cost inflation is a headwind.

Zacks Equity Research

Helen of Troy (HELE) Up More Than 20% in 3 Months: Here's Why

by Zacks Equity Research

Helen of Troy (HELE) is focused on developing the global restructuring plan, Project Pegasus. The company is benefiting from strength in its Leadership Brands.

Zacks Equity Research

Capacity Expansions Aid Lamb Weston (LW), High Costs Ail

by Zacks Equity Research

Lamb Weston (LW) is focused on strategic growth efforts like expanding capacity. However, cost inflation for key inputs like raw potatoes, energy and labor is a downside.

Zacks Equity Research

COTY's Q4 Earnings Underperform Estimates, Sales Increase

by Zacks Equity Research

COTY's fourth-quarter fiscal 2023 results reflect improved earnings and sales on gains from the Prestige & Consumer Beauty business.

Zacks Equity Research

Church & Dwight (CHD) Poised on Prudent Buyouts & Innovations

by Zacks Equity Research

Church & Dwight (CHD) has a long history of acquisitions, which are yielding. The company boasts a portfolio of solid brands.

Zacks Equity Research

Campbell Soup (CPB) Benefits From Saving Plans Amid High Costs

by Zacks Equity Research

Campbell Soup (CPB) is on track with efforts to counter inflation, such as supply-chain productivity enhancements and margin-improvement efforts.

Zacks Equity Research

Helen of Troy (HELE) Poised on Leadership Brands, Strategies

by Zacks Equity Research

Helen of Troy (HELE) is investing in its Leadership Brands that are yielding well. The company is focused on developing a global restructuring plan, Project Pegasus.

Zacks Equity Research

Lamb Weston (LW) Gains on Pricing Action Amid Cost Inflation

by Zacks Equity Research

Lamb Weston (LW) benefits from robust price/mix. Also, the company is focused on undertaking strategic growth efforts like expanding capacity.

Zacks Equity Research

Utz Brands (UTZ) Matches Q2 Earnings Estimates

by Zacks Equity Research

Utz Brands (UTZ) delivered earnings and revenue surprises of 0% and 0.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Inter Parfums (IPAR) Ups '23 EPS Guidance on Q2 Earnings Beat

by Zacks Equity Research

Inter Parfums' (IPAR) second-quarter 2023 results reflect higher earnings and sales on growth across Europe and U.S.-based operations. Management raises the 2023 earnings view.

Zacks Equity Research

Nomad Foods (NOMD) Tops Q2 Earnings Estimates

by Zacks Equity Research

Nomad Foods (NOMD) delivered earnings and revenue surprises of 4.76% and 0.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Medifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/Y

by Zacks Equity Research

Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.

Zacks Equity Research

Medifast (MED) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Medifast (MED) delivered earnings and revenue surprises of 92.36% and 16.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Tyson Foods (TSN) Q3 Earnings Miss Estimates, Sales Down Y/Y

by Zacks Equity Research

Tyson Foods' (TSN) fiscal third-quarter net sales and earnings decline year over year, reflecting challenging market dynamics. Management closes four Chicken facilities in the quarter.

Zacks Equity Research

Here's Why Pilgrim's Pride (PPC) is Well-Poised to Thrive

by Zacks Equity Research

Pilgrim's Prides' (PPC) unwavering focus on diversification, growth with Key Customers and operational excellence has been key to its success amid challenging market conditions.